gold

sponsor

gold

sponsor

Ethypharm webinar - How to review your buprenorphine prescribing and potentially lower your medically assisted treatment costs.

 

Please feel free to visit the Ethypharm webinar to look at a budget impact model and maybe arrange a follow up meeting for your organisation. On the webinar you will be able to see a live demonstration of the model and evaluate its use to your organisation. You can just visit and view the live demo, or if you wish either chat live or type questions to the Ethypharm staff they will be available throughout the day to help and assist you. You can visit the webinar anytime you wish between 08.00 and 16.00 on the day. To enter the webinar, you must either be a HCP or have an appropriate role within drug services.

 

Buprenorphine Prescribing Information can be found by clicking on the link:
https://www.ethypharm.co.uk/wp-content/uploads/sites/3/2019/11/Espranor-PI-May-2018.pdf

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Martindale Pharma, and Ethypharm Group Company.
Tel: 01277 266 600
email: drugsafety.uk@ethypharm.com

Date of preparation: September 2020
UK-ESP-52

About Ethypharm

Ethypharm a leading specialty pharmaceutical company with a strong heritage, based in the UK. Ethypharm acquired Martindale Pharma in January 2017 creating its position as a leading UK-based specialty pharmaceutical company providing value adding pharmaceutical products to over 80 countries around the world. We have developed a comprehensive range of medicines to support an individual’s recovery from opioid dependence. Our products include formulations of the three standard molecules in this therapy area; methadone, buprenorphine and naloxone. It is this depth of expertise that makes us a market leader and a trusted supplier of opioid dependence products.

The Ethypharm Team
David Orr
Health Care Development Manager Ethypharm Scotland and Northern Ireland

David has worked in his current role since 2017 supporting the roll out of the first Naloxone Peer network in the UK and working alongside SDF and other agencies to increase access to Take Home Naloxone. He has worked with Scottish Health Boards and prisons to facilitate the uptake of Espranor both helping to reduce costs and improve the patient experience. From 2000 onwards David worked in both the HIV and HEP C fields introducing new drugs to both these disease areas.  

Fiona Konteh
Ethypharm HealthCare Development Manager, Substance Dependency

 Fiona joined Martindale Pharma/Ethypharm in 2014  working across the Wales and the South West of England.

A strong advocate of Harm Reduction and Client centred treatment. Fiona previously worked in Service Redesign and Hospital Sales within Viral Hepatitis at Roche Pharmaceuticals as well as a range of companies and therapy areas in a career spanning 37 years. Trained originally and practiced as an Occupational Therapist working in acute psychiatry. 

Nicki Hough
Addiction Healthcare Development Manager

My role as an Addiction Healthcare Development Manager, covering London and the South East. I have worked within opioid dependency now for 18 years, and feel very passionate about addiction, and working with the client group that we do.

I am also a practitioner in Functional Medicine & Nutritional Science. I worked for myself for a few years, running my own clinic, as well as working with drug and alcohol services, and their clients within the addiction field.

Nina Bilbie 
Healthcare Development Manager, Substance Dependency

Nina joined Martindale Pharma/Ethypharm in 2012 and works across the East Midlands and East Of England. She has a background in both Pharmaceuticals and  Medical Devices of more than 35 years. A strong advocate of improving patient
 outcomes and harm reduction. Nina originally trained as a Physiotherapist.

Asia Rafiq
Healthcare Development Manager

Asia is the Healthcare Development Manager at Ethypharm for the North East and Yorkshire area. Asia has worked within Substance Dependency for nearly 4 years and is passionate about supporting services both within the 3rd sector and NHS by enabling access to cost effective medications and providing training solutions to healthcare professionals. Asia has worked in the pharmaceutical industry for over 20 years in various commercial roles across a broad range of therapy areas including Unlicensed Medicines and Pain Management.  Asia graduated in Biomedical Sciences and has a post graduate MBA.

Navin Kumar
Ethypharm HealthCare Development Manager, Substance Dependency

Navin joined Martindale Pharma/Ethypharm in 2017  working across the North West and Midlands. With a background in Economics, Navin has worked in substance dependency for         over 15 years. A strong advocate of improving patient outcomes, Navin has worked both as an NHS commissioner and more recently within the pharmaceutical industry.

 

If you need any further information or if you would like to arrange a call, please email
info@ethypharm.com

Join Ethypharm's Sponsor Webinar

Ethypharm is a leading pharmaceutical company within the opioid dependence and substance misuse sectors. Ethypharm have a team of Healthcare Development Managers waiting to discuss the products they offer such as Espranor as well as some interesting insight around their Budget Impact Modelling systems.  

Please note - To enter the webinar, you must either be a HCP or have an appropriate role within drug services. Please tick the following box to confirm you are a Health Care Professional.

If you have any question or want to follow up on anything from our page or webinar please do drop us an email at info@ethypharm.com 

Date of preparation: September 2020
UK-ESP-52

Keep up to date with the latest NHS APA news and events